Company Profile
Updated: 11-DEC-09Nabi Biopharmaceuticals
Exporter
12276 Wilkins Ave., Rockville, MD 20852-1834, United States
(800)685-5579, (301)770-3099, (301)770-3097 fax, http://www.nabi.com
Primary SIC: Biological Products Except Diagnostic, Primary NAICS: Biological Product (except Diagnostic) Manufacturing
Description: Manufacturing: Manufactures hepatitis B immune globulin.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
NABI BIOPHARMACEUTICALS REPORTS DISPOSITION BY DIRECTOR ARYEH (Florida)
US Fed News Service, Including US State News; 12/22/2009; 297 words; WASHINGTON, Dec. 22 -- Nabi Biopharmaceuticals (NABI), Boca Raton, Fla., has filed a Form 4 with the Securities and Exchange Commission noting the change in the beneficial interest held by Director Jason Aryeh, Greenwich, Conn. On Dec...
NEW VACCINE TO HELP QUIT SMOKING GETS TEST AT UNIVERSITY OF MARYLAND
US Fed News Service, Including US State News; 12/19/2009; 581 words; ...Glover is recruiting approximately 45 volunteers to participate in the study. The research is sponsored by Nabi Biopharmaceuticals. All smokers participating in the research study will be provided individual smoking cessation counseling...
Nabi Biopharmaceuticals To Receive $5 Million Milestone Payment.
Investrend; 12/11/2009; 615 words; ...financialwire.net/2009/12/11/nabi-biopharmaceuticals-to-receive-5-million-milestone...December 11, 2009 (FinancialWire) -- Nabi Biopharmaceuticals (NASDAQ: NABI) announced the initiation of a Phase I...
Pennystockchaser.com: www.pennnystockchaser.com: Penny Stock Chaser Alerts, December 9, 2009: NABI, HOGS, DGII and MFLX.
M2 Presswire; 12/9/2009; 1667 words; ...Pennystockchaser.com Alerts include Nabi Biopharmaceuticals (Nasdaq: NABI); Zhongpin...December 9, 2009 Nabi Biopharmaceuticals (Nasdaq:NABI) trading...volume of 87,849 shares Nabi Biopharmaceuticals to Receive $5 Million...
NABI BIOPHARMACEUTICALS FILES 10-Q (QUARTERLY REPORT)
US Fed News Service, Including US State News; 12/3/2009; 285 words; WASHINGTON, Dec. 3 -- Nabi Biopharmaceuticals, Rockville, Md., has filed a Form 10-Q on Nov. 5 for the third quarter ending Sept. 26 with the U.S. Securities and...
Recent News Articles
- Nabi Biopharmaceuticals (Nasdaq:NABI) Xtreme picks of the day!
M2 Presswire - June 03, 2009 - Nabi Biopharmaceuticals - Financial and Strategic Analysis Review.
M2 Presswire - May 06, 2009 - Q4 2008 Nabi Biopharmaceuticals Earnings Conference Call - Final.(Broadcast transcript)
Fair Disclosure Wire - March 11, 2009 - Nabi Biopharmaceuticals-Financial Company Report.
M2 Presswire - February 18, 2009
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning